Application

17392434 · COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN

Filed 2021-08-03 · Abandoned The official file ↗ · Art unit 1646 · Examiner Ruixiang Li Typical · CPC C07K 14/70578 · IMMUNEX CORPORATION · Marshall, Gerstein & Borun LLP (Amgen)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

21.3 mo

to disposition 27.8 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.